BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38636185)

  • 1. Septin-dependent defense mechanisms against Pseudomonas aeruginosa are stalled in cystic fibrosis bronchial epithelial cells.
    Brax S; Gaudin C; Calmel C; Boëlle PY; Corvol H; Ruffin M; Guillot L
    Eur J Cell Biol; 2024 Jun; 103(2):151416. PubMed ID: 38636185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll like Receptor signalling by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P. aeruginosa.
    Bertelsen A; Elborn SJ; Schock BC
    PLoS One; 2020; 15(10):e0235803. PubMed ID: 33031374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHAC1 Is Differentially Expressed in Normal and Cystic Fibrosis Bronchial Epithelial Cells and Regulates the Inflammatory Response Induced by
    Perra L; Balloy V; Foussignière T; Moissenet D; Petat H; Mungrue IN; Touqui L; Corvol H; Chignard M; Guillot L
    Front Immunol; 2018; 9():2823. PubMed ID: 30555487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.
    John G; Yildirim AO; Rubin BK; Gruenert DC; Henke MO
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):424-31. PubMed ID: 19502387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.
    Dechecchi MC; Nicolis E; Bezzerri V; Vella A; Colombatti M; Assael BM; Mettey Y; Borgatti M; Mancini I; Gambari R; Becq F; Cabrini G
    Am J Respir Cell Mol Biol; 2007 May; 36(5):615-24. PubMed ID: 17197571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa.
    Butterworth MB; Zhang L; Heidrich EM; Myerburg MM; Thibodeau PH
    J Biol Chem; 2012 Sep; 287(39):32556-65. PubMed ID: 22859302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids can affect Pseudomonas aeruginosa (ATCC 27853) internalization and intracellular calcium concentration in cystic fibrosis bronchial epithelial cells.
    Hussain R; Shahror R; Karpati F; Roomans GM
    Exp Lung Res; 2015; 41(7):383-92. PubMed ID: 26151838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vx-809/Vx-770 treatment reduces inflammatory response to Pseudomonas aeruginosa in primary differentiated cystic fibrosis bronchial epithelial cells.
    Ruffin M; Roussel L; Maillé É; Rousseau S; Brochiero E
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L635-L641. PubMed ID: 29351441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial interaction: Prevotella spp. reduce P. aeruginosa induced inflammation in cystic fibrosis bronchial epithelial cells.
    Bertelsen A; Elborn JS; Schock BC
    J Cyst Fibros; 2021 Jul; 20(4):682-691. PubMed ID: 34112603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial Epithelial Cells from Cystic Fibrosis Patients Express a Specific Long Non-coding RNA Signature upon
    Balloy V; Koshy R; Perra L; Corvol H; Chignard M; Guillot L; Scaria V
    Front Cell Infect Microbiol; 2017; 7():218. PubMed ID: 28611953
    [No Abstract]   [Full Text] [Related]  

  • 11. Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.
    Chattoraj SS; Ganesan S; Faris A; Comstock A; Lee WM; Sajjan US
    Infect Immun; 2011 Oct; 79(10):4131-45. PubMed ID: 21825067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial epithelial DNA methyltransferase 3b dampens pulmonary immune responses during Pseudomonas aeruginosa infection.
    Qin W; Brands X; Van't Veer C; F de Vos A; Sirard JC; J T H Roelofs J; P Scicluna B; van der Poll T
    PLoS Pathog; 2021 Apr; 17(4):e1009491. PubMed ID: 33793661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa Reduces VX-809 Stimulated F508del-CFTR Chloride Secretion by Airway Epithelial Cells.
    Stanton BA; Coutermarsh B; Barnaby R; Hogan D
    PLoS One; 2015; 10(5):e0127742. PubMed ID: 26018799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles secreted by primary human bronchial epithelial cells reduce
    Sarkar S; Barnaby R; Nymon AB; Taatjes DJ; Kelley TJ; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L164-L174. PubMed ID: 38084406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.
    Campodónico VL; Gadjeva M; Paradis-Bleau C; Uluer A; Pier GB
    Trends Mol Med; 2008 Mar; 14(3):120-33. PubMed ID: 18262467
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Li Z; Barnaby R; Nymon A; Roche C; Koeppen K; Ashare A; Hogan DA; Gerber SA; Taatjes DJ; Hampton TH; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L574-L588. PubMed ID: 38440830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis.
    Gardner AI; Wu Y; Verhaegh R; Liu Y; Wilker B; Soddemann M; Keitsch S; Edwards MJ; Haq IJ; Kamler M; Becker KA; Brodlie M; Gulbins E
    J Biol Chem; 2021; 296():100650. PubMed ID: 33839155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection.
    Halldorsson S; Gudjonsson T; Gottfredsson M; Singh PK; Gudmundsson GH; Baldursson O
    Am J Respir Cell Mol Biol; 2010 Jan; 42(1):62-8. PubMed ID: 19372247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxin A4 prevents tight junction disruption and delays the colonization of cystic fibrosis bronchial epithelial cells by Pseudomonas aeruginosa.
    Higgins G; Fustero Torre C; Tyrrell J; McNally P; Harvey BJ; Urbach V
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1053-61. PubMed ID: 27084849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
    Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
    PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.